Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Bio-Techne (TECH) over the last 16 years, with Q2 2025 value amounting to $2.8 million.

  • Bio-Techne's Short-term Investments fell 7102.82% to $2.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year decrease of 7102.82%. This contributed to the annual value of $2.8 million for FY2025, which is 7102.82% down from last year.
  • Latest data reveals that Bio-Techne reported Short-term Investments of $2.8 million as of Q2 2025, which was down 7102.82% from $3.2 million recorded in Q4 2024.
  • Bio-Techne's 5-year Short-term Investments high stood at $90.1 million for Q1 2021, and its period low was $2.8 million during Q2 2025.
  • In the last 5 years, Bio-Techne's Short-term Investments had a median value of $29.9 million in 2023 and averaged $33.0 million.
  • Per our database at Business Quant, Bio-Techne's Short-term Investments crashed by 7387.66% in 2021 and then surged by 12937.5% in 2022.
  • Over the past 5 years, Bio-Techne's Short-term Investments (Quarter) stood at $67.1 million in 2021, then tumbled by 52.22% to $32.1 million in 2022, then crashed by 63.87% to $11.6 million in 2023, then tumbled by 72.15% to $3.2 million in 2024, then decreased by 11.9% to $2.8 million in 2025.
  • Its Short-term Investments was $2.8 million in Q2 2025, compared to $3.2 million in Q4 2024 and $6.7 million in Q3 2024.